ISSN: 2161-0932
Vanda Salutari
Gynecology Oncology Unit, Policlinico Universitario Agostino Gemelli,
Rome
Spain
Commentary
Commentary on Bevacizumab in Ovarian Cancer: Focus on Clinical Data and Future Perspectives
Author(s): Vanda Salutari and Giovanni ScambiaVanda Salutari and Giovanni Scambia